Esperion Therapeutics Inc (ESPR)
2.36
-0.23
(-8.88%)
USD |
NASDAQ |
May 17, 16:00
2.38
+0.02
(+0.85%)
After-Hours: 20:00
Esperion Therapeutics Total Long Term Debt (Quarterly): 262.03M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 262.03M |
December 31, 2023 | 261.60M |
September 30, 2023 | 261.16M |
June 30, 2023 | 260.74M |
March 31, 2023 | 260.32M |
December 31, 2022 | 259.90M |
September 30, 2022 | 259.49M |
June 30, 2022 | 259.08M |
March 31, 2022 | 258.68M |
December 31, 2021 | 258.28M |
September 30, 2021 | 272.51M |
Date | Value |
---|---|
June 30, 2021 | 272.10M |
March 31, 2021 | 271.69M |
December 31, 2020 | 179.37M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
272.51M
Maximum
Sep 2021
179.85M
Average
259.28M
Median
Total Long Term Debt (Quarterly) Benchmarks
United Therapeutics Corp | 600.00M |
Dynavax Technologies Corp | 222.98M |
Heron Therapeutics Inc | 173.99M |
Aldeyra Therapeutics Inc | -- |
Deciphera Pharmaceuticals Inc | 0.00 |